<DOC>
	<DOCNO>NCT00459719</DOCNO>
	<brief_summary>The patient undergo liver transplantation randomize one follow two group : Group FK506MR : FK506MR/steroid ; Group Prograf® : Prograf® /steroid The treatment period 3 month ( 12 week</brief_summary>
	<brief_title>A Study Compare Efficacy Safety FK506MR v Prograf® Patients Undergoing Liver Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Written inform consent date patient must obtain . Patient 1870 year age receive primary liver . Female patient must negative pregnancy test prior enrolment . Female patient child bear potential must agree practice effective birth control study Liver retransplantation patient receive organ transplantation liver . Livingrelated liver transplantation patient . Patient receive AB0 incompatible donor liver . Patient need antibody induction therapy . Patient sever infection require treatment . Patient history severe cardiovascular , respiratory disease ; history malignancy , liver cancer include .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Liver Transplantation</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Methylprednisolone</keyword>
	<keyword>Prednisolone</keyword>
</DOC>